DOCSLIB.ORG

Mtg-Report-09-11-May-2018.Pdf (‎306.3Kb)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mtg-Report-09-11-May-2018.Pdf (‎306.3Kb) Regional dissemination workshop on Guidelines for HIV and Hepatitis B & C New Delhi, India, 09 - 11 May 2018 Regional Office for South-East Asia 1 © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party- owned component in the work rests solely with the user. General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. 2 Contents 1. Introduction .................................................................................................................................... 4 2. Objectives of the meeting ............................................................................................................... 4 3. Summary of workshop .................................................................................................................... 5 4. Conclusion ....................................................................................................................................... 9 Annex 1: Programme ............................................................................................................................ 10 Annex 2: List of participants ................................................................................................................. 14 Annex 3: Hepatitis country factsheets .................................................................................................. 19 3 1. Introduction Countries across the globe have committed themselves to achieve Sustainable Development Goals (SDGs). The SDG goal 3, specifically target 3.3 pertains to “end the epidemic of AIDS” and combating Hepatitis by 2030. To achieve this we need to fast track our response to HIV and scale up preventive and treatment interventions so as to reach 90:90:90 targets for HIV by 2020 and end stigma and discrimination related to HIV. Similar targets for hepatitis have been set to achieve 30% reduction in new infection of hepatitis B and C and 10 % reduction in hepatitis deaths by 2020 while increasing access to diagnosis and treatment. Recently WHO releaseda number of new guidelines on HIV self-testing, partner notifications, managing advanced HIV disease, PrEP, differentiated care, optimization of ART regimen and person centred patient monitoring guidelines. These guidelines and advances in prevention and treatment need to be used in a strategic way to advance the response to the KP-driven epidemics in the Region.The guideliens on hepatitis B and C are also under revision and countries are developing their own hepatitis guidelines and action plans. 2. Objectives of the meeting The general objective of meeting was to to disseminate recent updated HIV testing and treatment .and hepatitis B and C guidelines for building capacity of the national programme managers from member states and WHO country focal points.The specific objectives are: • To review the national and regional progress on response to address testing and treatment for HIV & Hepatitis and update recommendations on HIV and Hepatitis testing and treatment , including on community led and self- testing; and partner notification. • To review the contribution of Key Populations (KPs) in new infections, and revise approaches and implementation strategies to help address them adequately, including on how to reach the unreached. • To ensure that all HIV and Hepatitis programmes interventions contribute to the achievement of UHC, and make recommendations on specific actions that programmes can take to contribute to strengthening UHC. • To update the national programme managers, key CBOs, and WHO country focal points from member states on new WHO guidelines on HIV care including strategic information and hepatitis • hepatitis health sector response in Member States with timelines and resource needs identified. The participants included national programme manager for HIV and Hepatitis, focal person for M&E, HIV and Hepatitis, academia and institutes of excellence, WHO Collaborating Centres, Development partners, and community stakeholder. The agenda is in Annexure-I and list of participants is at Annexure-II. This report summarizes the major findings from the discussions in the meeting. 4 To begin the workshop, Dr Swarup Sarkar, Director, Communicable diseases delivered the welcome address. Dr B B Rewari, Scientist-HIV at SEARO shared a progress update on global and regional burden for HIV and hepatitis. The WHO SEARO Regional Director, in her speech, highlighted the progress so far. Globally the coverage of antiretroviral therapy (ART) has increased to nearly 20 million, or about 70% of the estimated 36 million people living with HIV (PLHIV). The 2016 WHO guidelines recommended providing antiretroviral treatment to all those detected positive irrespective of clinical stage or CD4 count. This is expected to prevent 17 million new infections and also about 10.8 million HIV-related deaths by 2030. The South-East Asia Region of WHO has the second highest number of people living with HIV with an estimated 3.5 million, out of which nearly 1.6 million are on ART. So far SEA Region countries have been able to avoid an explosive increase in HIV infections or deaths and are all showing declining trends. 3. Summary of workshop The meeting started with Dr Swarup sarkar welcoming the participants and he also read out the speech by the Regional Director WHO SEARO, who could not attend the meeting due to some other pressing engagement . The text of RD address is as below: Mr. Alok Saxena, Joint secretary, NACO Programme managers and WHO focal points from SEAR countries Invited HIV and Hepatitis experts At the outset I would like to welcome you to this workshop on dissemination of the recent WHO Guidelines on HIV and Hepatitis. It is a matter of extreme satisfaction to all of us that the global response to HIV has seen unprecedented successes with most countries having controlled or reversed the epidemic as envisaged in one of the Millennium Development Goals .We are now at a historic moment in our fight against HIV having embarked on a mission to end the AIDS epidemic as a public health threat by 2030 as part of Sustainable Development Goal 3.3. We need to very cautious not to be complacent due to our successes and ensure that HIV prevention and treatment service are available in a manner that is accessible to all, including key populations, under the overarching umbrella of universal health coverage. In June 2016, the UN general assembly adopted a Political Declaration on HIV/AIDS that called for reducing new HIV infections and AIDS related deaths to fewer than 500 000 globally and eliminating 5 HIV-related stigma and discrimination by 2020. The Political Declaration also affirmed that these goals can only be realized with strong leadership and the engagement of people
Load more

Recommended publications
  • DRAFT Guidelines for Behavior Change Interventions to Prevent HIV
    DRAFT Guidelines for Behavior Change Interventions to Prevent HIV Sharing Lessons from an Experience in Bangladesh Based on the Application of Lessons from Sonagachi, Kolkata. Best Practice Collection from the Region, UNAIDS South Asia Inter Country Team 1 Guidelines for Behavior Change Interventions to Prevent HIV-Sharing Lessons from an Experience in Bangladesh, Based on Applying learning from Sonagachi, India published by UNAIDS Inter Country Team for South Asia, New Delhi 2003- All rights reserved. This document, which is not a formal publication of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or full, provided the source is acknowledged. The document may not be sold or used in conjunction with commercial purposes without priori written approval of UNAIDS ( Contact: UNAIDS Information Center) The document expressed in documents any named authors are solely the responsibility of these authors. The designations employed and the presentation of the material in this work do not imply the expression of any opinion whatsoever on the part of UNAIDS concerning the legal status of any country, testimony, city or area or of its authorities, or concerning the delimitation of its frontiers and boundaries The mention of specific organisations, companies or of certain manufacturers products does not imply that they are endorsed or recommended by UNAIDS in preference to others of a similar nature that are not mentioned . Errors and omissions are excepted, the names of proprietary products are distinguished by initial capital letters. Contributing Author: Geeta Sethi and Smarajit Jana Consulting Editor : Deepika Ganju Support in design and lay out: Enamul Haque & Yasmin Acknowledgements: This manual heavily draws from a training module written by CARE Bangladesh in 1997.
    [Show full text]
  • Epidemic of Abuse — Police Harassment
    July 2002 Vol 14, No 5 (C) INDIA EPIDEMIC OF ABUSE: POLICE HARASSMENT OF HIV/AIDS OUTREACH WORKERS IN INDIA [ADVANCE COPY] Table of Contents I. SUMMARY...........................................................................................................................................................3 II. RECOMMENDATIONS .....................................................................................................................................6 To the Government of India ...................................................................................................................................6 To the National AIDS Control Organisation..........................................................................................................6 To the World Bank, United Nations agencies and bilateral donors supporting HIV/AIDS programs in India: ....7 III. METHODS .........................................................................................................................................................7 IV. BACKGROUND: HIV/AIDS IN INDIA ...........................................................................................................8 V. ABUSES AGAINST HIV/AIDS OUTREACH WORKERS ............................................................................11 Human rights abuses linked to HIV/AIDS outreach to women in prostitution....................................................11 Human rights abuses linked to HIV/AIDS outreach to men who have sex with men..........................................19
    [Show full text]
  • Costing Guidelines for HIV/AIDS Intervention Strategies
    ADB - UNAIDS Study Series : Tool I Costing Guidelines for HIV/AIDS Intervention Strategies For use in estimating Resource Needs, Scaling-up and Strategic Planning in the Asia/Pacific region February 2004 This document is a collaborative work of the Asian Development Bank, UNAIDS, Futures Group International and Ease International and forms a part of the training material used to cost pre- vention and care activities at local, country and regional level. Contributors (in alphabetical or- der): Anita Alban, Michael Hahn, Catherine Hankins, Sigit Priohutomo, Myat Htoo Razak, DCS Reddy, Swarup Sarkar and John Stover. The primary spreadsheet INPUT for Nepal was pro- duced by Anita Alban and Michael Hahn; the regional version was developed by Vidya Ganesh, DCS Reddy and Shyam Sundar, editing and review by Adriana Gomez, Michael Hahn, Tony Lisle, Rebecca Moss, Lee-Nah Hsu, Rober Greenner and Swarup Sarkar. Views expressed in this document do not necessarily reflect the official position of UNAIDS and Asian Development Bank. UNAIDS/04.41E (English, original, February 2004) ISBN 974-91970-6-2 First Edition, February 2004 © Joint United Nations Programme on HIV/AIDS (UNAIDS) & Asian Development Bank (ADB), 2004 All rights reserved. This document, which is not a formal publication of UNAIDS and ADB, may be freely reviewed, quoted, reproduced or translated, in part or full, provided the source is acknowledged. The document may not be sold or used in conjunction with commercial pur- poses without prior written approval of UNAIDS or ADB (please contact the UNAIDS Information Centre, UNAIDS, Geneva or ADB, Manila). The views expressed in documents by named au- thors are the sole responsibility of those authors.
    [Show full text]
  • Geographic Hotspots and Key Populations
    Identifying Populations at Greatest Risk of Infection – Geographic Hotspots and Key Populations Report and recommendations from a meeting of the UNAIDS Reference Group on Estimates, Modeling and Projections held in Geneva, Switzerland, 25-26 July 2013 1 Introduction The Joint United Nations Programme on HIV/AIDS (UNAIDS) Reference Group on Estimates, Modelling and Projections exists to provide impartial scientific advice to UNAIDS, the World Health Organization (WHO) and other partner organizations on global estimates and projections of the prevalence, incidence and impact of HIV/AIDS. The Reference Group acts as an ‘open cohort’ of epidemiologists, demographers, statisticians, and public health experts. It is able to provide timely advice and also address ongoing concerns through both ad hoc and regular meetings. The group is coordinated by a secretariat based in the Department of Infectious Disease Epidemiology, Imperial College London. Meeting objectives The main objectives of this consultation are to: 1. Discuss and advise whether and how a more granular representation of prevalence, incidence and risk at different administrative levels could better convey the need for programming in line with the nature of the local epidemic. 2. Discuss and advise how improvements can be made in the analysis and presentation of the manifold higher risk of infection of key populations compared to the rest of the population in different parts of the world, in view of triggering action, and in view of changing epidemic trends. 3. Discuss and assess the potential impact of applying geographical data analysis to improve programme efficiency. Three main outcomes will be developed following the meeting: 1. Meeting report 2.
    [Show full text]
  • Men Who Have Sex with Men the Missing Piece in National Responses to AIDS in Asia and the Pacific UNAIDS
    Men who have sex with men the missing piece in national responses to AIDS in Asia and the Pacific UNAIDS UNAIDS (English original, July 2007) © Joint United Nations Programme on HIV/AIDS (UNAIDS) 2007. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of UNAIDS concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. UNAIDS does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. UNAIDS RSTAP 9th Floor, Block A, United Nations Building, Rajdamnern Nok Avenue, Bangkok 10200, Thailand Tel: 66 (0) 2288 2497-8 Fax: 66 (0) 2288 1092 20 avenue Appia, CH-1211 Geneva 27, Switzerland Tel: (+41) 22 791 36 66 Fax: (+41) 22 791 48 35 Email: [email protected] Website: www.unaids.org UNAIDS Acknowledgements This paper was written as a background paper for “Male Sexual Health and HIV in Asia and the Pacific International Consultation: Risks and Responsibilities,” held in New Delhi, India, 22nd -26th September 2006. UNAIDS gratefully acknowledges the advice, guidance and support given by the MSM and Transgender community members involved all across the region without whose support this publication would not have been possible. Many colleagues in UNAIDS country and Geneva offices also helped in editing the publication. We express special gratitude to the following persons who significantly contributed to this publication, namely: Aditya Bondyoapdhyay, Andrew Wilson, Billy Pick, Clif Cortez, David Bridger, Frits van Griensven, Gayle Martin, Geoff Manthey, Jan W de Lind van Wijngaarden, Michel Carael, Paul Causey, Phillippe Girault, Purnima Mane, Shivananda Khan, Swarup Sarkar, Tim Brown and Tracey Newbury.
    [Show full text]
  • Inaugural Meeting of the Strategic and Technical Advisory Group on Disease Elimination (Virtual Meeting) Meeting Report and Recommendations
    Inaugural Meeting of the Strategic and Technical Advisory Group on Disease Elimination (Virtual Meeting) Meeting Report and Recommendations 14-15 October 2020 Inaugural Meeting of the Strategic and Technical Advisory Group on Disease Elimination, 14–15 October 2020. Meeting Report and Recommendations PAHO/CDE/HT/21-0009 © Pan American Health Organization, 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO license (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this license, this work may be copied, redistributed, and adapted for non-commercial purposes, provided the new work is issued using the same or equivalent Creative Commons license and it is appropriately cited. In any use of this work, there should be no suggestion that the Pan American Health Organization (PAHO) endorses any specific organization, product, or service. Use of the PAHO logo is not permitted. All reasonable precautions have been taken by PAHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall PAHO be liable for damages arising from its use. Contents Introduction ................................................................................................................................................... 2 1. Objectives .............................................................................................................................................
    [Show full text]
  • Evaluation of the Indonesian Aksi Stop Aids Program
    PROCUREMENT SENSITIVE INFORMATION NOT FOR PUBLIC RELEASE UNTIL JANUARY 2009 EVALUATION OF THE INDONESIAN AKSI STOP AIDS PROGRAM Submitted to USAID/Jakarta by Jack Reynolds, The Synergy Project Gani Perla, The Synergy Project Suriadi Gunawan, The Synergy Project Izhar Fihir, The Synergy Project Elapully Haran, The Synergy Project Billy Pick, USAID/ANE/TS Ratna Kurniawati, USAID/Indonesia Lisa Kramer, USAID/Indonesia Jeanne Uktolseja, MOH/CDC Swarup Sakar, UNAIDS October 2004 EXECUTIVE SUMMARY Scope of Work: Over a three-week period, a 10-person team conducted an evaluation of the Aksi Stop AIDS (ASA) program. The evaluation concentrated on achievement of the program’s five Results Packages. The fundamental question was whether or not ASA should be continued, either as designed or with modifications. The team spent the first week interviewing ASA staff and other informants, the second week visiting implementing agencies (IAs) in Papua, North Sulawesi, and Central Java. Most of the third week was spent drafting the report and debriefing USAID, ASA, the Ministry of Health (MOH), and others. The Epidemiological Situation: Indonesia’s epidemic remains a concentrated one, with the possible exception of Papua, which appears to be spreading to the general population. In addition to Papua, the provinces with the largest number of infections appear to be Jakarta DKI and East Java. The groups most at risk are injecting drug users (IDUs), clients of female sex workers, partners of high-risk groups, men who have sex with men (MSM), female sex workers (FSW), and transvestites. Behavioral surveillance surveys have shown that knowledge about HIV/AIDS is high, but that this knowledge has little effect on behavior.
    [Show full text]
  • GHSN Quarterly Newsletter
    GHSN Quarterly Newsletter Q2 January 2021 In this Issue • Happy New Year • Introducing the GHSN Board • Call for Action #SustainWHO • Latest Global Health Meetings • Latest Health Security News • GHSN Sponsors Happy New Year Our Mission 2021 is finally upon us and many will be relieved to see the back Our mission is to create an international of 2020! community of academics, scientists and policy- makers who seek to share their knowledge and It was a big year for the GHSN with our official launch 7 months research on global health security. ago, and we are so grateful for our fantastic members and the support we have received from them. We encourage free thinking and support those that wish to make a meaningful impact to The GHSN has lots of exciting plans in place for 2021, kicking the improve the health and well-being of all people year off with the release of our 2nd policy report which will globally. discuss vaccine misinformation. We also have many interesting speakers lined up for our fortnightly webinars. Keep an eye out The GHSN community is an opportunity to on our website for more details! engage with members, sharing their ideas through the Association and at GHSN events We hope you have a fantastic year ahead and would like to take around the world. the opportunity to thank you again for your continued support. The Global Health Security Network Board A/Prof Adam Kamradt-Scott Adam specialises in global health security and international relations. His research and teaching explore how governments and multilateral organisations cooperate and interact when adverse health events such as disease outbreaks, epidemics and pandemics occur, as well as how they respond to emerging health and security challenges.
    [Show full text]
  • Rapid Assessment and Response Guide on Injecting Drug Use (IDU-RAR)
    WHO/HSC/SAB Original: English Distr.: Limited . Draft for field testing, MAY 1998 SUBSTANCE ABUSE DEPARTMENT The Rapid Assessment and Response guide on injecting drug use (IDU-RAR) SOCIAL CHANGE AND MENTAL HEALTH WORLD HEALTH ORGANIZATION This guide was prepared for the World Health Organization Substance Abuse Department (WHO/SAB) It was prepared by Professor Gerry V. Stimson, Chris Fitch and Tim Rhodes, at the The Centre for Research on Drugs and Health Behaviour Department of Social Science and Medicine Imperial College School of Medicine London, United Kingdom Technical support/contributions were provided by: Moruf Adelekan (University of Ilorin, Nigeria) Andrew Ball (WHO/SAB) Martin Donoghoe (WHO/SAB) Augusto Perez-Gomez (Universidad de los Andes, Colombia) Sujata Rana (WHO/SAB and UNAIDS/PSR) Swarup Sarkar (UNAIDS) Gundo Aurel Weiler (WHO/SAB) THIS IS A DRAFT DOCUMENT. USERS ARE REQUESTED TO PROVIDE ANY FEEDBACK AND COMMENTS TO WHO/SAB Provisional reference details: World Health Organization - Substance Abuse Department (1998) The Rapid Assessment and Response Guide on Injecting Drug Use (Eds. G.V.Stimson, C.Fitch and T.Rhodes). © World Health Organization Correspondence addresses: The Centre for Research Substance Abuse Department on Drugs and Health Behaviour, Cluster on Social Change and Mental Health 200 Seagrave Road, World Health Organization, London, 1211 Geneva 27, SW6 1RQ, Switzerland United Kingdom Tel: 41 22 791 21 11 Fax: 41 22 791 4851 Tel: 44 181 846 6557 email [email protected] Fax: 44 181 846 6505 email [email protected]
    [Show full text]
  • Cost-Effective Interventions That Focus on Most-At-Risk Populations
    Draft Working Paper Cost‐Effective Interventions that Focus on Most‐at‐Risk Populations Swarup Sarkar, Manager, Asia Programs, The Global Fund to Fight AIDS, Tuberculosis and Malaria; principal contributing author, Independent Commission for AIDS in Asia (OUP 2008) Natalie Menser, Research Support Staff, aids2031 Costs and Financing Project, and Department of International Health, Georgetown University William McGreevey, Consulting Health Economist, aids2031 Costs and Financing Project, and Associate Professor, Department of International Health, Georgetown University Draft Working Paper Table of Contents Introduction...............................................................................................................................................5 Denial, disapproval, and behavioural risks among MARPs.......................................................6 Resource needs among MARPs, evolving estimates and approaches.................................8 Benefits and costs of spending to address AIDS prevention among MARPs..................10 Who will pay?..........................................................................................................................................12 Next steps and future projections into 2031...............................................................................16 Tables 1) Global estimate, population of MARPs 2) Asia region country example of resource needs for HIV and AIDS activities, US millions 3) Expenditure on MSM programming, 2004, selected countries and regions (nominal
    [Show full text]